« Schepens Scientists Regenerate Optic Nerve for the First Time | Main | Biogen, Elan Voluntarily Withdraw MS Drug »
Biogen, Elan Suspend Tysabri After Death
Biogen Idec and Elan Corporation Plc on Monday suspended sales of their much-heralded new multiple sclerosis drug Tysabri after a patient died from a rare but frequently fatal central nervous system disease.
More here.
February 28, 2005 in antegren , bummer, follow the money..., treatment, tysabri | Permalink
